Search for: "Novartis Pharma AG "
Results 21 - 40
of 124
Sorted by Relevance
|
Sort by Date
9 Feb 2014, 9:15 pm
Reddy's Laboratories Ltd. et al. 1:14-cv-00157; filed February 5, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendants: Dr. [read post]
8 Feb 2015, 9:59 pm
Roxane Laboratories Inc. 1:15-cv-00128; filed February 5, 2015 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendant: Roxane Laboratories Inc. [read post]
4 Jan 2015, 9:21 pm
Roxane Laboratories Inc. 1:14-cv-01508; filed December 23, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendant: Roxane Laboratories Inc. [read post]
28 Dec 2014, 9:49 pm
Par Pharmaceutical Inc. 1:14-cv-01494; filed December 18 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendant: Par Pharmaceutical Inc. [read post]
19 Mar 2010, 4:13 am
The FDA is considering expanding the warning labels of the Novartis AG cream Elidel (pimecrolimus) and AStellas Pharma’s Protopic (tacrolimus) used to treat eczema. [read post]
10 May 2010, 9:34 pm
By James DeGiulio -- Celgene and Novartis Reach Settlement with Barr Laboratories in Ritalin ANDA Suit Celgene Corp. and Novartis AG have reached a settlement with Barr Laboratories Inc. over Barr's attempt to market a generic version of the ADHD drug Ritalin. [read post]
16 Sep 2016, 4:07 am
A related issue was whether Novartis Pharma AG (Novartis) was the exclusive licensee of Orion’s 765932 patent and had the right to sue for infringement in these proceedings. [read post]
7 Nov 2019, 8:10 pm
., 37%; Novo Nordisk AS, 17%; Novartis AG, 14%; and Merck KGa, 13%; Hoffmann-La Roche, 12.7%). [read post]
26 Apr 2021, 7:42 am
Novartis AG is working with Pfizer Inc. to fill vials quicker and to develop the mRNA needed for a new vaccine candidate produced by CureVA NV. [read post]
22 Sep 2020, 2:15 pm
" Returning to the recent announcement about that Phase 3 study, we get the following from this September 14, 2020 Fierce Pharma article, "Novartis, stressing Beovu safety, matches Eylea in head-to-head diabetic macular edema trial": Normally, late-stage trial announcements center on a drug’s efficacy, but Novartis singled out Beovu’s safety performance in its statement. [read post]
5 May 2013, 11:10 am
A new lawsuit suggests that it wasn't for Big Pharma player Novartis AG—the company was charged last month with fraud, allegedly for paying kickbacks to pharmacies that switched transplant patients from a less expensive generic drug to to its brand name med, Myfortic. [read post]
30 Aug 2011, 5:18 am
Teva, the world's largest generic drug company, won a court battle in SDNY in its role as a proprietary drug company making Copaxone, against Novartis AG's Sandoz unit, Momenta Pharmaceuticals Inc., Mylan Inc., and Natco Pharma Ltd. [read post]
7 Jun 2008, 3:34 am
Yesterday, Forbes.com reported that Novartis AG spent almost $1.3 million in the first quarter of 2008 on lobbying. [read post]
24 Jan 2022, 5:03 am
So what happened in Novartis Pharma AG and others ./. [read post]
12 Oct 2011, 3:46 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
21 Sep 2011, 2:36 am
Novartis AG v Actavis UK Limited (The SPC blog) (The SPC blog) Europe: Note on recent ECJ Memantine and Galantamine rulings (The SPC blog) US: Federal Circuit denies petition for rehearing in AMP v. [read post]
28 Sep 2011, 1:56 am
The AG’s opinion in Georgetown and Medeva (The SPC blog) Hungary: Repeatedly filed request for preliminary injunction – micronized active ingredient (EPLAW) Indonesia pharma patents and generic manufacture (IP Komodo) South Africa: Traditional Knowledge Bill debate – your views needed (Afro-IP) (Afro-IP) (Afro-IP) UK: Second round consultation on Patent Box proposal (including SPCs) ends (The SPC Blog) US: CAFC: Patent exhaustion does not apply to genetically… [read post]
18 Dec 2009, 9:59 am
(patent infringement) 12/10: Seattle Children's Hospital, Novartis AG, Novartis Vaccines and Diagnostics, Inc. and Novartis Pharmaceuticals Corporation v. [read post]
15 May 2017, 2:32 am
Novartis AG. [read post]
29 Jun 2011, 3:34 am
(Patent Docs) Deferacirox – India: Cipla wins pre grant opposition (593/CHENP/2005): Novartis v. [read post]
